Industry & Policy News

[Florida Atlantic University] Three Florida Atlantic University researchers at the forefront of Alzheimer’s disease research have each received a $350,000 grant from the Florida Department of Health’s “Ed and Ethel Moore Alzheimer’s Disease Research Program.

[AC Immune SA] Takeda and AC Immune SA announced a worldwide option and license agreement for AC Immune’s active immunotherapies targeting toxic forms of amyloid beta, including ACI-24.060 for the treatment of Alzheimer’s disease.

[Washington University School of Medicine in St. Louis] Researchers at Washington University School of Medicine in St. Louis have received a $5 million grant from the Leukemia & Lymphoma Society to support research aimed at developing new immunotherapies for different types of blood-based cancers.

[University of Arkansas (EurekAlert)] The National Science Foundation (NSF) awarded $630,444 to Kathleen Paul, an assistant professor of anthropology at the University of Arkansas, to provide a comprehensive outline of dental genetic architecture for two primate species of tamarins and macaques.

[Utrecht University] A team of researchers from Utrecht University and UMC Utrecht has received a grant of 936,587 euros from the ZonMw Open Competition for research into a serious heart condition that affects both humans and dogs, especially Dobermanns.

[Oncolytics Biotech, Inc.] Oncolytics Biotech® Inc. will commence enrollment into a new GOBLET study pancreatic cancer cohort following both German regulatory and ethics approvals. This cohort will evaluate pelareorep in combination with modified FOLFIRINOX with or without the PD-L1 immune checkpoint inhibitor atezolizumab in newly diagnosed patients with PDAC.